Co-Authors
This is a "connection" page, showing publications co-authored by RODABE N AMARIA and FUNDA MERIC-BERNSTAM.
Connection Strength
0.408
-
Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers. Cancer. 2021 02 01; 127(3):391-402.
Score: 0.186
-
Physician interpretation of genomic test results and treatment selection. Cancer. 2018 03 01; 124(5):966-972.
Score: 0.152
-
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification. Ann Oncol. 2018 06 01; 29(6):1445-1453.
Score: 0.039
-
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol. 2015 Feb; 135(2):508-515.
Score: 0.030